Syndax Pharmaceuticals, Inc. (SNDX) Net margin 2016–2025
Syndax Pharmaceuticals, Inc. (SNDX) net profit margin by fiscal year — reported net income divided by reported revenue.
-165.6%FY2025 · since FY2016: -3645.2% → -165.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -165.6% | +1180.7 pp |
| FY2024 | -1346.3% | — |
| FY2021 | 17.8% | +4840.4 pp |
| FY2020 | -4822.5% | -1127.9 pp |
| FY2019 | -3694.6% | +1180.9 pp |
| FY2018 | -4875.5% | -1991.1 pp |
| FY2017 | -2884.3% | +760.9 pp |
| FY2016 | -3645.2% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice